Presentation of Ewing’s Sarcoma In Unlikely Age Group at Unusual Location
Keywords:
Ewing’s Sarcoma, Primitive neuroectodermal tumor (PNET), Ewing family of tumours (EFT), Round cell tumor.Abstract
Ewings sarcoma is highly malignant, round cell neoplasm of uncertain origin. It is the sixth most common malignant tumor of bone. It must be distinguished from chronic osteomyelitis and other malignant round cell tumors like lymphoma, metastatic neuroblastoma and small cell osteosarcoma. Most patients are between 10 to 25years old, rarely patients are younger than age 5 years and older than age 40 years. We report a 55 year female who presented with swelling over right shoulder with pain and inability to move right shoulder later diagnosed as Ewing’s sarcoma of proximal part of humerus right side. The earlier diagnosis at this age may help in better management of the condition and prevent further complications and have better prognosis
Downloads
References
Joseph M. Mirra, Piero Picci: Ewing's sarcoma In: Bone tumors- clinical, radiologic, and pathologic correlations, volume two, Lea & Febiger, Philadelphia, London 1 989, pp. 1088-1094.
Stout AP. A tumor of the ulnar nerve. Proc NY Pathol Soc 1918; 12:2-12.
Ewing J. Diffuse endothelioma of bone. Proc NY Pathol Soc 1921;21:17-24.
Angervall L, Enzinger FM. Extraskeletal neoplasm resembling Ewing's sarcoma. Cancer 1975;36:240-51.
Jaffe R, Santamaria M, Yunis EJ, Tannery NH, Agostini RM Jr, Medina j, era/. The neuroectodermal tumor of bone. Am j Surg Patho 1984;8:885-98.
Gurney JG, Swensen AR, Bulterys M. Malignant bone tumors. In: Ries LA, etal, editors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995 Bethesda, MD: National Cancer institute. SEER Program. NIH Pub. No, 99-4649; 1999 99-110.
Zamora P, Garcia de Paredes ML, Gonzalez .Baron M, Diaz MA, Escobar Y, Ordonez A, et al. Ewing's tumor in brothers. An unusual observation. AmJ Clin Oncol 1986; 9:358-60.
Kim, T.E., Ghazi G. Atkinson G. ct al.: Ewing's sarcoma of a lower extremity in an infant: A therapeutic dilemma. Cancer, 5c: 187, 1986.
Nascimento AG, Unii KK, Pritchard DJ, Cooper KL, Dahlin DC. A clinicopathologic study of 20 cases of large-cell (atypical) Ewing's sarcoma of bone. AmJ Surg Pathol 1980; 4:29-36.
Khoury JD. Ewing sarcoma family of tumors. AdV Anat Pathol 2005; 12:212-20.
Nilsson G, Wang M, Wejde J, Kreicbergs A,Larsson O. Detection of EWS/FL1-1 by immunostaining. An adjunctive tool in diagnosis of Ewing's sarcoma and primitive neuroectodermal tumour on cytological samples and paraffin- embedded archival material. Sarcoma 1999 3:25-32.
Saral S desai, Nirmala A Jambhekar. Desai and jambhekar: Pathology of ES/PNET. Indian journal of orthopaedics. 2010;44:363-368.
Delattre O, Zucman J, Plougastel B, Desmaze C, MelotT, Peter M, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992; 359:162-5.
Ludwig JA. Ewing sarcoma: Historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future. Curr Opin Oncol 2008; 20:412-8.
Abaan OD, Levenson A, Khan 0, Furth PA, Uren A, Toretsky JA. PTPL1 is a direct transcriptional target of EWS-FL11 and modulates Ewing's Sarcoma tumorigenesis. Oncogene 2005; 24:2715-22.
Greene FL, Page DL, Fleming ID , A. Fritz, C.M Balch, D.G. Haller et al, eds. AJCC cancer staging Manual. 6th ed. New York, NY: Springer; 2002.
Rodriguez -Galindo C, Liu T, Krasin MJ, Wu J, Billups CA, Daw NG, et al. Analysis of prognostic factors in Ewing's Sarcoma tamily of tumors: review of St. Jude chilaren s research hospital studies cancer 2007; 1 10:375-84.
Cotterill SJ, Ahrens S, Paulussen M. Voute PA, Gadner H et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patient from the European intergroup cooperative Ewings sarcoma study group. J clin oncol 2000;18:3108-14.
Bacci G, Longhi A, Ferrari S, Mercuri M Versari M. Bertoni F Prognostic factors in non-metass Ewing's sarcoma tumor of bone: An analysis 579 patients treated at a single at a at a single institution with adjuvant or neo-adjuvant 1998.Actachemotherapy between 1972 and 1998.Act oncol 2006; 45:469-75.
Burgert EO Jr, Nesbit ME, Garnsey LA , Gehan EA, Herrmann J, Vietti TJ, et al. Multimodal therapy for management of non-pelvic , localized Ewing's sarcoma of bone :intergroup study IESS. II. JClin Oncol 1990;8:1514-24.
Granowetter L, Womer R, Devidas M, Karlio M Wang C, Bernstein M, et al. Dose –intensified compared with standard chemotherapy for non- metastatic Ewing's sarcoma family of tumors: a children's oncology group study. J clin oncol 2009; 27:2536-41.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
